GGrantIndex
← Leaderboards

Vera L. Tarakanova

Washington University

$6,716,721
Attributed
$6,928,471
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $771.9K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,928,471 · 8

By mechanism

R01$5,282,337 · 3
R21$1,252,132 · 3
R56$378,260 · 1
F32$15,742 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionViralGammaherpesvirusMalignant NeoplasmsResponseChronicVirusAdultPathogenesisStructure Of Germinal Center Of Lymph NodeVirus LatencyB-Cell LymphomasMolecularAnimal ModelInsightVirus DiseasesHuman Herpesvirus 4LymphomagenesisGeneticRisk FactorsSignal TransductionB Cell DifferentiationMemory B-LymphocyteLymphoma

Grant awards (24)

Gammaherpesvirus protein kinase: a master manipulator of the host during chronic infection.$519,342
R01 · FY2025 · AI · contact PI
From friend to foe: proviral role of IRF-3 in chronic gammaherpesvirus infection$191,148
R21 · FY2025 · AI · contact PI
From friend to foe: proviral role of IRF-3 in chronic gammaherpesvirus infection$248,517
R21 · FY2024 · AI · contact PI
Gammaherpesvirus protein kinase: a master manipulator of the host during chronic infection.$127,559
R01 · FY2024 · AI · contact PI
Gammaherpesvirus protein kinase: a master manipulator of the host during chronic infection.$534,942
R01 · FY2023 · AI · contact PI
Gammaherpesvirus protein kinase: a master manipulator of the host during chronic infection.$548,942
R01 · FY2022 · AI · contact PI
Gammaherpesvirus and IL-17: using host antibacterial defense to benefit chronic virus infection$174,857
R21 · FY2022 · CA · contact PI
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis$365,250
R01 · FY2021 · CA · contact PI
Gammaherpesvirus and IL-17: using host antibacterial defense to benefit chronic virus infection$214,110
R21 · FY2021 · CA · contact PI
Chronic gammaherpesvirus infection and high cholesterol: Adding fuel to the fire$192,500
R21 · FY2021 · AI · contact PI
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis$424,117
R01 · FY2020 · CA · contact PI
Chronic gammaherpesvirus infection and high cholesterol: Adding fuel to the fire$231,000
R21 · FY2020 · AI · contact PI
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis$341,706
R01 · FY2019 · CA · contact PI
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis$69,686
R01 · FY2019 · CA · contact PI
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis$352,275
R01 · FY2018 · CA · contact PI
ATM and gammaherpesvirus infection: a precarious balance$317,475
R01 · FY2018 · CA · contact PI
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis$58,868
R01 · FY2018 · CA · contact PI
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis$352,275
R01 · FY2017 · CA · contact PI
ATM and gammaherpesvirus infection: a precarious balance$317,475
R01 · FY2017 · CA · contact PI
ATM and gammaherpesvirus infection: a precarious balance$317,475
R01 · FY2016 · CA · contact PI
ATM and gammaherpesvirus infection: a precarious balance$317,475
R01 · FY2015 · CA · contact PI
ATM and gammaherpesvirus infection: a precarious balance$317,475
R01 · FY2014 · CA · contact PI
The role of gammaherpesvirus protein kinase in lytic and latent infection$378,260
R56 · FY2010 · AI · contact PI
Regulation of gHV68-induced B cell proliferation$15,742
F32 · FY2005 · AI